AACR 2023 Conference Coverage
AACR 2023 on KEYNOTE-966 Phase 3 Study: Pembro in Combination With Gemcitabine & Cisplatin for Advanced Biliary Tract Cancer
By
AACR 2023 Conference Coverage
FEATURING
Katie Kelley
By
AACR 2023 Conference Coverage
FEATURING
Katie Kelley
Comments 1
Login to view comments.
Click here to Login